Latest filing published 11 Mar 2025 for Elicera Therapeutics AB (publ), €8,697.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Rolf Ingvar Lennart Karlsson: trading record in brief
Filings by Rolf Ingvar Lennart Karlsson span 2 companies, the busiest being Elicera Therapeutics AB (publ) and Elicera Therapeutics AB. Over a trading history stretching from 10 June 2021 to 11 March 2025, the count stands at 5 filings.
Every open-market trade on record is a purchase: 1 purchase worth €9,959, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants.
Most recently, on 11 March 2025, the filings show a transaction worth €8,697 in Elicera Therapeutics AB (publ). The clock since the last published purchase (5 July 2021) now reads 1,952 days. Publication is fast: at least half of the trades appear on Finansinspektionen on the same day. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Rolf Ingvar Lennart Karlsson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 51,600 shares@ SEK 1.8546.6% of flowInterimsaktieISIN SE0015382080FI:csv-6c3dd28b6ab5651f0fe2
- 4,800 shares@ SEK 16.2039.2% of flowBTU (betald tecknad unit)ISIN SE0021626306FI:csv-5688932e2b4fe70b0b80
- 23,500 shares@ SEK 4.3056.2% of flowAktieISIN SE0015382080FI:csv-4fc00d8c95cd4264b51aCanonical exit: 3 Oct 2021 (T+90)
- 12,500 shares@ SEK 8.00100.0% of flowAktieISIN SE0015382080FI:csv-ed2f24c16654e6c5059b
- 12,500 shares0OptionISIN SE0015988233FI:csv-5002fdba579325170821
5 of 5 declarations